StemCyte opened in 1997 as the only major U.S. private cord blood bank that began as a public bank. That dual model became the foundation of everything we do. Labs in California and Taiwan, 2,300+ units shipped worldwide, FDA-licensed product (REGENECYTE®, US License 2280).
That dual mission, private storage for families and public donation for patients, became the foundation of everything we do. Today, we are one of the few cord blood banks in the world that operates both, side by side.
From laboratories in California and Taiwan, StemCyte has shipped more than 2,300 cord blood units for transplant in 40 countries, one of the highest clinical utilization rates in the industry.
